Ross Muken
Stock Analyst at Evercore ISI Group
(2.08)
# 2,723
Out of 4,828 analysts
40
Total ratings
57.14%
Success rate
0.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: In-Line | $190 → $225 | $138.79 | +62.12% | 6 | Nov 7, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $360 → $350 | $133.96 | +161.27% | 7 | Oct 8, 2024 | |
| HSIC Henry Schein | Maintains: In-Line | $70 → $74 | $68.64 | +7.81% | 8 | Oct 8, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $106.93 | +21.57% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $41.86 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $148.22 | -54.80% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $75.76 | +229.99% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $403.13 | -45.43% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $16.30 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Nov 7, 2024
Maintains: In-Line
Price Target: $190 → $225
Current: $138.79
Upside: +62.12%
ICON Public Limited Company
Oct 8, 2024
Maintains: Outperform
Price Target: $360 → $350
Current: $133.96
Upside: +161.27%
Henry Schein
Oct 8, 2024
Maintains: In-Line
Price Target: $70 → $74
Current: $68.64
Upside: +7.81%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $106.93
Upside: +21.57%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $41.86
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $148.22
Upside: -54.80%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $75.76
Upside: +229.99%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $403.13
Upside: -45.43%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $16.30
Upside: -